PBYI · Company research
PUMA BIOTECHNOLOGY INC (PBYI): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 9.81 | $516,498,503.98 | 426650503.98 | 61.3750000000000000 | — | 1.8412499999999991 | 9.1412428583059007 | 17.5268419009806916 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.